Dexelion provides a software solution for real-time depth map extraction for commercial CIS(CMOS Image Sensor)-based cameras such as Dual- and Quad-pixel sensors.
SubµLED
Venture Round in 2022
SubµLED develops and mass produces micro LED light source PKG, which is a key component of next-generation displays.
Peeper is a Star-Fan Q&A platform. “Fans ask, Star answers.” On Peeper, The fans can ask a question to their favorite star and can get an answer from the star. If a question gather more than 10,000 fans wants, Stars do answers with Voice and Pictures. Peeper is a Q&A based interactive social media platform between stars and fans. Peeper was developed to solve the limitations of the one-way communication between star and fans in the existing social media like Instagram and Twitter. The existing social media is being used as a tool to show off the nice selfies of the stars, and fans had to just tap “Like” or leave comments like “Love it”. Still it remains one-sided form to get the fan’s reaction. On Peeper, the fans can ask questions to the star in the ‘Ask’ tab of star’s Peeper account. Stars will answer questions that are asked by a lot of fans by showing something that fans want to see or even answer questions via voice messages. The star’s answer is provided with the star’s own photo and the voice message recorded by the star him/herself, so it provides a much more special experience to the fans both at home and abroad. Also It enables direct interaction between the star and the fans.
Wave-I
Venture Round in 2018
Wave-I is an independent entity that curates and produces art exhibitions that introduces the works of established and emerging artists.
Hessed Edu develops STEAM content that consists of more than 500 STEAM contents and adopted by 500 educational institutes covering 3 through 10 years old.
SENSORTOPIA develops rain sensors that check the raindrop status and activate the automatic wiper system without any attention from the driver.
GaGyo Tech
Venture Round in 2017
GaGyo Tech develops a prototype of a non-Virus DBD plasma air purifier for vehicles. The company's patented technology generates a magnetic field by adding variable current to plasma and removing harmful substances.
Kozaza, Book Homes in Korea (kozaza is a Korean word meaning 'sleep well as baby') Kozaza is a home sharing platform foccused on Korea. You can find a unique and affordable place to stay at https://kozaza.com/en. There are variety of choices: homestays, houses, apartments, studio, guesthouses, pension, templestays, and Hanoks, Korean trandtional houses. Kozaza has been designated as a sharig company by Seoul Metropolital Government since 2013. With the partnership from local governments, Kozaza is bringing a new accommodation culture in Korea for foreign visitors. We are located and specialized in Seoul, Korea. We could serve you with better local services. You will also save your money because Kozaza charges lower service fee with special promotions with local hosts. We are proud to host Eric Schmidt, chairman of Google, Park Wonsoon, mayor of Seoul, and Neal Gorenflo, co-founder of Shareable. Check out https://kozaza.com/en Contact us at help@kozaza.com or (+82)1544-5665(BOOK) Cheers, Kozaza Team
ARTIFEX
Venture Round in 2017
ARTIFEX is a production specialty company for the walking frame that helps elderly people who have difficulty moving around.
SPRYFIT is a platform for fitness challenges. Using any wearable device and fitness app, our virtual fitness communities help people achieve their health goals through collaboration, competition, and cash prizes. We combine the underutilized health data of wearables and smartphones with the motivating power of money.
GFLAS Life Sciences, Inc. is poised to disrupt the agricultural biotechnology sector with its pioneering advancements in CRISPR-Cas genome editing technology. Founded by Dr. Sunghwa Choe in 2014, GFLAS has swiftly established itself as a leader in biotech innovation, dedicated to enhancing human health and promoting agricultural sustainability through cutting-edge genetic engineering solutions. Our flagship innovation, the world's first vitamin D3-enriched tomatoes, addresses a critical market need by transforming the traditional tomato industry. Tomatoes are one of the most consumed vegetables globally, with the US fresh tomato market alone valued at approximately $18 billion annually, assuming an average price of $1.5 per kilogram. The consumer market value is even more substantial, estimated between $27 to $31.5 billion annually. By introducing vitamin D3-enriched tomatoes, GFLAS not only adds significant nutritional value to a staple food product but also creates a unique selling proposition that meets the increasing consumer demand for functional foods. The strategic partnership with Bayer, a global leader in agricultural science, underscores the commercial viability and substantial market potential of our technology. This collaboration has facilitated the transfer of GFLAS's vitamin D3 tomato technology to Bayer Crio Science in the USA, providing a robust pathway for large-scale commercialization and global market penetration. This partnership not only validates our technological prowess but also positions us for significant growth in the global agricultural market. Our vitamin D3-enriched tomatoes offer numerous advantages over traditional vitamin D supplements. They provide a sustainable, plant-based source of vitamin D3, catering to vegans, vegetarians, and individuals with dietary restrictions or limited sun exposure. Unlike vitamin D3 derived from animal sources, our tomatoes are free from the risk of chemical contamination, making them a safer and more natural alternative. Furthermore, incorporating vitamin D3 into a widely consumed food product enhances consumer acceptance and adherence to recommended dietary intakes. The market potential for our innovations is immense. By capturing a significant share of the $18 billion US wholesale tomato market, our vitamin D3-enriched tomatoes can appeal to health-conscious consumers and address the needs of populations at risk of vitamin D deficiency. Additionally, our enhanced CRISPR-Cas technologies offer transformative possibilities across various agricultural applications, positioning GFLAS for sustained growth and profitability. We are now seeking investment to accelerate our expansion and capitalize on the lucrative opportunities within the US market and beyond. Our financial projections indicate substantial growth, with a target of achieving 30% market share within four years. The infusion of capital will support scaling up production, enhancing quality control, and expanding distribution and marketing efforts. GFLAS Life Sciences invites private equity funds and strategic investors to join us in this groundbreaking venture. With our cutting-edge technologies, strong partnerships, and clear market potential, GFLAS is uniquely positioned to deliver substantial returns on investment while making a profound positive impact on global health and sustainability. We look forward to discussing this exciting investment opportunity further and exploring how we can work together to bring our revolutionary products to market.
Olive Healthcare is a digital healthcare and medical diagnostic devices company. It is focused on abdominal fat scanning and breast cancer diagnosis, using nonradiative and noninvasive near infrared (NIR) technology, artificial intelligence (AI) algorithms, and big data processing for a customized medical service.
Genesystem is a biotech engineering company specializing in instrumentation of molecular diagnostics devices. It develops and markets state-of-the-art PCR instruments as well as related reagents and microfluidic devices which are designed to enhance the health of human societies and ultimately improve the quality of human life. The company is also open for customized engineering services for the clients in biotechnology industry. Genesystem assures it clients that that companies engineering expertise and know-how would create greater values their client’s application.
ViroCure, Inc. develops multiple viruses for cancer therapeutics and vaccine development. It offers viruses that helps to infect and kill cancer cells, and activate anti-cancer immune. The company provides RC402, that kills metastatic gastric cancer and lung cancer; RP116, that helps to kill oral cancers, salivary gland cancer, soft tissue sarcoma, and melanoma; MC509, a naturally occurring rabbit-specific poxvirus; and SC717, that fights oncolytic against tumor-bearing animals. The company is headquartered in Seoul, South Korea.
JE Lab
Venture Round in 2015
JE Lab develop world first feet stretching machine and individual customized stretching service.
MPros retains application technologies in various medical diagnostic devices. MPROS proceeds with hardware circuit design and signal processing algorithm establishment including the creation of integrated sensors for the development of an IoT-based sleep management system.
Dot Pad — The first tactile graphics display for the visually impaired. (https://www.youtube.com/watch?v=DaxlpMj1sxU) Dot Kiosk - The most accessible kiosk for the disabled and everyone in a smart city.
Cremotech is a manufacturer of optical products. They provide products that include laser light sources. They provide products for media devices. An online inquiry form is available on the company's website.
Tempus is an infrared sensor manufacturing company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.